Vav Life Sciences, a little known nanotech research company, made an “accidental” entry into making specialised lipids used in targeted drug delivery.
This has put the company in a small circle of just four global players making phospholipids, for mRNA vaccines.
Vav Life Sciences' Managing Director Arun Kedia explains the significance of targeted drug delivery, which is hailed as the medicine of tomorrow. The “silver bullet” or “sniper” approach helps deliver the medicine to the precise diseased cell.
Edited: by Gitanjali Diwakar
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.